A detailed history of Core Cap Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Core Cap Advisors, LLC holds 1,039 shares of HLN stock, worth $10,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,039
Holding current value
$10,078
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$8.32 - $10.7 $8,644 - $11,117
1,039 New
1,039 $10,000
Q1 2024

Aug 08, 2024

BUY
$8.02 - $8.67 $12,535 - $13,551
1,563 New
1,563 $13,000
Q4 2022

Feb 10, 2023

BUY
$5.96 - $8.06 $9,089 - $12,291
1,525 New
1,525 $12,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.